NDC 72903-853

ELAHERE

Mirvetuximab Soravtansine

ELAHERE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Immunogen, Inc.. The primary component is Mirvetuximab Soravtansine.

• Product ID: 72903-853_0a19fa56-07a8-46b8-ab69-f6c83d725d56
• NDC: 72903-853
• Product Type: Human Prescription Drug
• Proprietary Name: ELAHERE
• Generic Name: Mirvetuximab Soravtansine
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-11-14
• Marketing Category: BLA /
• Application Number: BLA761310
• Labeler Name: ImmunoGen, Inc.
• Substance Name: MIRVETUXIMAB SORAVTANSINE
• Active Ingredient Strength: 100 mg/20mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72903-853-01

1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) > 20 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2022-11-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details